These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3286510)

  • 1. Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.
    Zeiler HJ; Beermann D; Wingender W; Förster D; Schacht P
    Infection; 1988; 16 Suppl 1():S19-23. PubMed ID: 3286510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
    Well M; Naber KG; Kinzig-Schippers M; Sörgel F
    Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.
    Zeiler HJ
    Drugs Exp Clin Res; 1985; 11(5):335-8. PubMed ID: 2941261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy.
    Zeiler HJ; Metzger KG; Schacht P; Grohe K
    Drugs Exp Clin Res; 1985; 11(5):343-50. PubMed ID: 2941263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers.
    Machka K; Milatovic D
    Eur J Clin Microbiol; 1987 Feb; 6(1):59-62. PubMed ID: 3106034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary pharmacodynamics of low-dose ciprofloxacin and ofloxacin.
    Stein GE; Schooley S; McMillan J
    Diagn Microbiol Infect Dis; 1998 Apr; 30(4):261-5. PubMed ID: 9582586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers.
    Israel D; Gillum JG; Turik M; Harvey K; Ford J; Dalton H; Towle M; Echols R; Heller AH; Polk R
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2193-9. PubMed ID: 8257144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
    Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.
    Hofbauer H; Naber KG; Kinzig-Schippers M; Sörgel F; Rustige-Wiedemann C; Wiedemann B; Reiz A; Kresken M
    Infection; 1997; 25(2):121-6. PubMed ID: 9108190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative pharmacokinetics of five quinolones.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
    Cruciani M; Monzillo V; Navarra A; Tinelli C; Concia E
    Drugs Exp Clin Res; 1988; 14(8):533-7. PubMed ID: 3150350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin.
    Lehto P; Kivistö KT; Neuvonen PJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):82-5. PubMed ID: 8148225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humours of patients by different topical application modes.
    von Keyserlingk J; Beck R; Fischer U; Hehl EM; Guthoff R; Drewelow B
    Eur J Clin Pharmacol; 1997; 53(3-4):251-5. PubMed ID: 9476040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
    Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mode of action of 4-quinolones and possible mechanisms of resistance.
    Smith JT
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():21-9. PubMed ID: 3542946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro antibacterial activity of piperacillin/quinolone combinations].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):357-60. PubMed ID: 3136421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.